Notice Regarding Repurchase of Own Shares
Filed with TSE · · 1 page · English
Summary by 6ix AI
Daito Pharmaceutical Co., Ltd. has announced the repurchase of its own shares as per the provisions of the Companies Act of Japan and its Articles of Incorporation. The company repurchased a specific number of common stock shares during a designated period. The total amount spent on the repurchase is also disclosed in the filing. This notice serves to inform stakeholders about the details of the share repurchase initiative.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Daito Pharmaceutical Co., Ltd. on 6ix
Earlier from Daito Pharmaceutical
- [Summary] Summary of Consolidated Financial Results for the Three Months Ended August 31, 2026 (Under Japanese GAAP)
- Notice Concerning the Acquisition of Treasury Shares and the Cancellation of Treasury Shares
- FY2027 1Q Earnings Presentation
- Execution of JV and Share Transfer Agreement for Transfer of KYORIN Pharmaceutical's Generic Drug Business to JV by Daito, Meiji Seika Pharma and DBJ
- FY2026 4Q Earnings Presentation
Follow Daito Pharmaceutical into a list and get an email when it puts out news.
Follow Daito Pharmaceutical